NAT10 and hepatocellular carcinoma: We show that the mRNA stabilities of CYP2C9 and PIK3R1 are not regulated by NAT10 upon chemotherapy, indicating that NAT10 promotes chemoresistance in HCC by activating the transcription of the downstream genes instead of modifying mRNA.